{"id":"https://openalex.org/W1977488162","doi":"https://doi.org/10.1097/00005344-198103000-00009","title":"Cardiovascular Properties of Medroxalol, A New Antihypertensive Drug","display_name":"Cardiovascular Properties of Medroxalol, A New Antihypertensive Drug","publication_year":1981,"publication_date":"1981-03-01","ids":{"openalex":"https://openalex.org/W1977488162","doi":"https://doi.org/10.1097/00005344-198103000-00009","mag":"1977488162","pmid":"https://pubmed.ncbi.nlm.nih.gov/6166802"},"language":"en","primary_location":{"id":"doi:10.1097/00005344-198103000-00009","doi":"https://doi.org/10.1097/00005344-198103000-00009","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00005344-198103000-00009","pdf_url":null,"source":{"id":"https://openalex.org/S61167191","display_name":"Journal of Cardiovascular Pharmacology","issn_l":"0160-2446","issn":["0160-2446","1533-4023"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Cardiovascular Pharmacology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5041210262","display_name":"Richard C. Dage","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Richard C. Dage","raw_affiliation_strings":["Merrell Research Center, Merrell-National Laboratories, Division of Richardson-Merrell Inc., Cincinnati, Ohio"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merrell Research Center, Merrell-National Laboratories, Division of Richardson-Merrell Inc., Cincinnati, Ohio","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111770119","display_name":"Hsien C. Cheng","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hsien C. Cheng","raw_affiliation_strings":["Merrell Research Center, Merrell-National Laboratories, Division of Richardson-Merrell Inc., Cincinnati, Ohio"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merrell Research Center, Merrell-National Laboratories, Division of Richardson-Merrell Inc., Cincinnati, Ohio","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5035939378","display_name":"James K. Woodward","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"James K. Woodward","raw_affiliation_strings":["Merrell Research Center, Merrell-National Laboratories, Division of Richardson-Merrell Inc., Cincinnati, Ohio"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merrell Research Center, Merrell-National Laboratories, Division of Richardson-Merrell Inc., Cincinnati, Ohio","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":6.6645,"has_fulltext":false,"cited_by_count":36,"citation_normalized_percentile":{"value":0.9673475,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":89,"max":94},"biblio":{"volume":"3","issue":"2","first_page":"299","last_page":"316"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10144","display_name":"Blood Pressure and Hypertension Studies","score":0.9887999892234802,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10144","display_name":"Blood Pressure and Hypertension Studies","score":0.9887999892234802,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11178","display_name":"Receptor Mechanisms and Signaling","score":0.007699999958276749,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T14486","display_name":"Cardiovascular, Neuropeptides, and Oxidative Stress Research","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/antihypertensive-drugs","display_name":"antihypertensive drugs","score":0.9290000200271606},{"id":"https://openalex.org/keywords/blood-pressure-reduction","display_name":"blood pressure reduction","score":0.7490000128746033},{"id":"https://openalex.org/keywords/alpha-adrenergic-receptor-antagonism","display_name":"alpha-adrenergic receptor antagonism","score":0.8769999742507935},{"id":"https://openalex.org/keywords/beta-adrenergic-receptor-antagonism","display_name":"beta-adrenergic receptor antagonism","score":0.9959999918937683},{"id":"https://openalex.org/keywords/adrenergic-blockade","display_name":"adrenergic blockade","score":0.8090000152587891},{"id":"https://openalex.org/keywords/systemic-vascular-resistance","display_name":"systemic vascular resistance","score":0.9240000247955322},{"id":"https://openalex.org/keywords/cardiac-output","display_name":"cardiac output","score":0.7440000176429749},{"id":"https://openalex.org/keywords/heart-rate","display_name":"heart rate","score":0.7509999871253967},{"id":"https://openalex.org/keywords/vasodilation","display_name":"vasodilation","score":0.7940000295639038},{"id":"https://openalex.org/keywords/isoproterenol","display_name":"isoproterenol","score":0.7829999923706055},{"id":"https://openalex.org/keywords/phenylephrine","display_name":"phenylephrine","score":0.9860000014305115},{"id":"https://openalex.org/keywords/phentolamine","display_name":"phentolamine","score":0.7710000276565552},{"id":"https://openalex.org/keywords/propranolol","display_name":"propranolol","score":0.8510000109672546},{"id":"https://openalex.org/keywords/spontaneously-hypertensive-rats","display_name":"spontaneously hypertensive rats","score":0.8820000290870667},{"id":"https://openalex.org/keywords/dogs","display_name":"dogs","score":0.36500000953674316}],"concepts":[{"id":"https://openalex.org/C2780253649","wikidata":"https://www.wikidata.org/wiki/Q420360","display_name":"Phentolamine","level":3,"score":0.9375296831130981},{"id":"https://openalex.org/C2777952589","wikidata":"https://www.wikidata.org/wiki/Q421910","display_name":"Phenylephrine","level":3,"score":0.7964373826980591},{"id":"https://openalex.org/C2778151854","wikidata":"https://www.wikidata.org/wiki/Q423364","display_name":"Propranolol","level":2,"score":0.7141744494438171},{"id":"https://openalex.org/C84393581","wikidata":"https://www.wikidata.org/wiki/Q82642","display_name":"Blood pressure","level":2,"score":0.7110946178436279},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.637846052646637},{"id":"https://openalex.org/C120770815","wikidata":"https://www.wikidata.org/wiki/Q14859627","display_name":"Vasodilation","level":2,"score":0.5956103801727295},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5552487373352051},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.5325779914855957},{"id":"https://openalex.org/C2777953023","wikidata":"https://www.wikidata.org/wiki/Q1073121","display_name":"Heart rate","level":3,"score":0.5170938968658447},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4821881353855133},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.4669645130634308},{"id":"https://openalex.org/C2776885963","wikidata":"https://www.wikidata.org/wiki/Q245204","display_name":"Antagonist","level":3,"score":0.4586678743362427},{"id":"https://openalex.org/C139940330","wikidata":"https://www.wikidata.org/wiki/Q596579","display_name":"Cardiac output","level":3,"score":0.45341169834136963},{"id":"https://openalex.org/C2778468042","wikidata":"https://www.wikidata.org/wiki/Q273976","display_name":"Blockade","level":3,"score":0.4523216485977173},{"id":"https://openalex.org/C158453852","wikidata":"https://www.wikidata.org/wiki/Q4684738","display_name":"Adrenergic","level":3,"score":0.42374396324157715}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000959","descriptor_name":"Antihypertensive Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D001794","descriptor_name":"Blood Pressure","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D002319","descriptor_name":"Cardiovascular System","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D004285","descriptor_name":"Dogs","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004983","descriptor_name":"Ethanolamines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D006168","descriptor_name":"Guinea Pigs","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006439","descriptor_name":"Hemodynamics","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006973","descriptor_name":"Hypertension","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D007741","descriptor_name":"Labetalol","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009200","descriptor_name":"Myocardial Contraction","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D011817","descriptor_name":"Rabbits","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011941","descriptor_name":"Receptors, Adrenergic","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D013565","descriptor_name":"Sympatholytics","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D066298","descriptor_name":"In Vitro Techniques","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1097/00005344-198103000-00009","doi":"https://doi.org/10.1097/00005344-198103000-00009","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00005344-198103000-00009","pdf_url":null,"source":{"id":"https://openalex.org/S61167191","display_name":"Journal of Cardiovascular Pharmacology","issn_l":"0160-2446","issn":["0160-2446","1533-4023"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Cardiovascular Pharmacology","raw_type":"journal-article"},{"id":"pmid:6166802","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/6166802","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of cardiovascular pharmacology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9391000270843506}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2046507913","https://openalex.org/W2054948476","https://openalex.org/W2031092046","https://openalex.org/W2408785249","https://openalex.org/W1994681127","https://openalex.org/W2027974976","https://openalex.org/W1973465221","https://openalex.org/W2084531321","https://openalex.org/W2012834015","https://openalex.org/W83944202"],"abstract_inverted_index":{"Medroxalol":[0,27,88],"is":[1,7],"a":[2,29,106,156],"new":[3],"antihypertensive":[4,50],"agent":[5],"that":[6,66,147],"presently":[8],"undergoing":[9],"clinical":[10],"trial.":[11],"Its":[12],"cardiovascular":[13],"properties":[14],"were":[15],"studied":[16],"using":[17],"spontaneously":[18],"hypertensive":[19],"rats":[20],"(SHR),":[21],"anesthetized":[22],"dogs,":[23,55],"and":[24,61,85,92,98,118,136,172,183],"isolated":[25],"tissues.":[26],"produced":[28],"long-lasting":[30],"fall":[31,157],"in":[32,49,100,112,121,158],"blood":[33,59,93,159],"pressure":[34,60,94,160],"when":[35],"given":[36],"by":[37,161,195],"the":[38,58,148,191],"oral":[39],"route":[40],"to":[41,54,96,154],"SHR.":[42],"It":[43,127,144],"was":[44,78,128,145,153],"more":[45,166,177],"potent":[46,131,139],"than":[47,167,178],"phentolamine":[48,133],"effectiveness.":[51],"Given":[52],"intravenously":[53],"medroxalol":[56,77,104,152],"reduced":[57,79],"heart":[62,90],"rate":[63,91],"of":[64,76,151],"doses":[65],"did":[67],"not":[68,81,188],"greatly":[69],"reduce":[70],"cardiac":[71,168,179],"output.":[72,169,180],"The":[73],"hypotensive":[74],"effect":[75],"but":[80],"abolished":[82],"following":[83],"alpha-":[84,171,182],"beta-adrenergic-receptor":[86],"blockade.":[87],"inhibited":[89],"responses":[95],"isoproterenol":[97],"phenylephrine":[99],"dogs.":[101],"In":[102],"vitro":[103],"resembled":[105],"competitive":[107],"antagonist":[108],"at":[109,134,142],"alpha-adrenergic":[110],"receptors":[111,120],"rabbit":[113],"aortic":[114],"strips":[115],"(pA2":[116,125],"6.09)":[117],"beta-adrenergic":[119],"guinea":[122],"pig":[123],"atria":[124],"7.73).":[126],"0.02":[129],"as":[130,132,138,140],"alpha-receptors":[135],"0.09":[137],"propranolol":[141],"beta-receptors.":[143],"concluded":[146],"principal":[149],"action":[150],"produce":[155],"decreasing":[162],"peripheral":[163],"vascular":[164],"resistance":[165],"Adrenergic":[170,181],"beta-receptor":[173,184],"blockade":[174,185],"alone":[175,186],"does":[176,187],"satisfactorily":[189],"explain":[190],"hypotension.":[192],"A":[193],"contribution":[194],"an":[196],"active":[197],"vasodilatory":[198],"component":[199],"appears":[200],"likely.":[201]},"counts_by_year":[{"year":2019,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}